| Criterion Text | Inclusion/Exclusion | Disease | Biomarker | Prior Therapy | Criterion Rule |
| --- | --- | --- | --- | --- | --- |
| Prior anti-cancer monoclonal antibody (mAb) within 4 weeks prior to study Day 1 or not recovered from an adverse event caused by mAbs administered more than 4 weeks earlier | Exclusion |  |  | Monoclonal antibody therapy | Not recovered from an adverse event caused by mAbs administered more than 4 weeks earlier OR (monoclonal antibody therapy within 4 weeks prior to study Day 1) |

Explanation:

* Criterion Text: The text of the exclusion criterion is "Prior anti-cancer monoclonal antibody (mAb) within 4 weeks prior to study Day 1 or not recovered from an adverse event caused by mAbs administered more than 4 weeks earlier."
* Inclusion/Exclusion: This is an exclusion criterion, so the value is "Exclusion."
* Disease: This criterion does not mention a specific disease, so this column is left blank.
* Biomarker: This criterion does not mention a specific biomarker, so this column is left blank.
* Prior Therapy: This criterion mentions prior monoclonal antibody therapy, so the value is "Monoclonal antibody therapy."
* Criterion Rule: The criterion